Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Ann Neurol
2014 Apr 01;754:581-90. doi: 10.1002/ana.24128.
Show Gene links
Show Anatomy links
KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine.
Milligan CJ
,
Li M
,
Gazina EV
,
Heron SE
,
Nair U
,
Trager C
,
Reid CA
,
Venkat A
,
Younkin DP
,
Dlugos DJ
,
Petrovski S
,
Goldstein DB
,
Dibbens LM
,
Scheffer IE
,
Berkovic SF
,
Petrou S
.
???displayArticle.abstract???
OBJECTIVE: Mutations in KCNT1 have been implicated in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) and epilepsy of infancy with migrating focal seizures (EIMFS). More recently, a whole exome sequencing study of epileptic encephalopathies identified an additional de novo mutation in 1 proband with EIMFS. We aim to investigate the electrophysiological and pharmacological characteristics of hKCNT1 mutations and examine developmental expression levels.
METHODS: Here we use a Xenopus laevis oocyte-based automated 2-electrode voltage clamp assay. The effects of quinidine (100 and 300 μM) are also tested. Using quantitative reverse transcriptase polymerase chain reaction, the relative levels of mouse brain mKcnt1 mRNA expression are determined.
RESULTS: We demonstrate that KCNT1 mutations implicated in epilepsy cause a marked increase in function. Importantly, there is a significant group difference in gain of function between mutations associated with ADNFLE and EIMFS. Finally, exposure to quinidine significantly reduces this gain of function for all mutations studied.
INTERPRETATION: These results establish direction for a targeted therapy and potentially exemplify a translational paradigm for in vitro studies informing novel therapies in a neuropsychiatric disease.
Allen,
De novo mutations in epileptic encephalopathies.
2013, Pubmed
Allen,
De novo mutations in epileptic encephalopathies.
2013,
Pubmed
Barcia,
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.
2012,
Pubmed
,
Xenbase
Berg,
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.
2010,
Pubmed
Bhattacharjee,
For K+ channels, Na+ is the new Ca2+.
2005,
Pubmed
Bhattacharjee,
Localization of the Slack potassium channel in the rat central nervous system.
2002,
Pubmed
Bhattacharjee,
Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel inhibited by ATP.
2003,
Pubmed
,
Xenbase
Candenas,
Molecular diversity of voltage-gated sodium channel alpha and beta subunit mRNAs in human tissues.
2006,
Pubmed
Castle,
Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog.
1991,
Pubmed
Coppola,
Migrating partial seizures in infancy: a malignant disorder with developmental arrest.
1995,
Pubmed
Derry,
Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability.
2008,
Pubmed
Du,
Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder.
2005,
Pubmed
,
Xenbase
Harashima,
Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
1985,
Pubmed
Hellemans,
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data.
2007,
Pubmed
Heron,
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.
2012,
Pubmed
Ishii,
A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.
2013,
Pubmed
Joiner,
Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.
1998,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Markham,
A sodium-activated potassium channel supports high-frequency firing and reduces energetic costs during rapid modulations of action potential amplitude.
2013,
Pubmed
McTague,
Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.
2013,
Pubmed
Petrou,
P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype.
1997,
Pubmed
,
Xenbase
Petrovski,
Genic intolerance to functional variation and the interpretation of personal genomes.
2013,
Pubmed
Ramsey,
Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis.
2009,
Pubmed
Santi,
Opposite regulation of Slick and Slack K+ channels by neuromodulators.
2006,
Pubmed
,
Xenbase
Sierra,
Sodium-dependent plateau potentials in electrocytes of the electric fish Gymnotus carapo.
2005,
Pubmed
Tamsett,
NAD+ activates KNa channels in dorsal root ganglion neurons.
2009,
Pubmed
Vandesompele,
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
2002,
Pubmed
Yang,
Pharmacological activation and inhibition of Slack (Slo2.2) channels.
2006,
Pubmed
,
Xenbase
Yang,
An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing.
2010,
Pubmed
,
Xenbase
Yuan,
The sodium-activated potassium channel is encoded by a member of the Slo gene family.
2003,
Pubmed
,
Xenbase
de Los Angeles Tejada,
Clofilium inhibits Slick and Slack potassium channels.
2012,
Pubmed
